AUTHOR'S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Optimizing and Refining Immunotherapy in Breast Cancer

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Cesar A. Santa-Maria

Consulting or Advisory Role: Polyphor, Genomic Health, Halozyme, Bristol Myers Squibb, Athenex, Seattle Genetics, Merck, Pfizer

Research Funding: Medimmune (Inst), Pfizer (Inst), Tesaro (Inst), Bristol Myers Squibb (Inst), AstraZeneca (Inst), Merck (Inst)

No other potential conflicts of interest were reported.